Updates are available Correction dated 2022-09-23
Click to view Correction: https://doi.org/10.1038/s41586-022-05300-0
-
Authors
Bethlehem, R. A. I.
Seidlitz, J.
White, S. R.
Vogel, J. W.
Anderson, K. M.
Adamson, C.
Adler, S.
Alexopoulos, G. S.
Anagnostou, E.
Areces-Gonzalez, A.
Astle, D. E.
Auyeung, B.
Ayub, M.
Bae, J.
Ball, G.
Baron-Cohen, S.
Beare, R.
Bedford, S. A.
Benegal, V.
Beyer, F.
Blangero, J.
Blesa Cábez, M.
Boardman, J. P.
Borzage, M.
Bosch-Bayard, J. F.
Bourke, N.
Calhoun, V. D.
Chakravarty, M. M.
Chen, C.
Chertavian, C.
Chetelat, G.
Chong, Y. S.
Cole, J. H.
Corvin, A.
Costantino, M.
Courchesne, E.
Crivello, F.
Cropley, V. L.
Crosbie, J.
Crossley, N.
Delarue, M.
Delorme, R.
Desrivieres, S.
Devenyi, G. A.
Di Biase, M. A.
Dolan, R.
Donald, K. A.
Donohoe, G.
Dunlop, K.
Edwards, A. D.
Elison, J. T.
Ellis, C. T.
Elman, J. A.
Eyler, L.
Fair, D. A.
Feczko, E.
Fletcher, P. C.
Fonagy, P.
Franz, C. E.
Galan-Garcia, L.
Gholipour, A.
Giedd, J.
Gilmore, J. H.
Glahn, D. C.
Goodyer, I. M.
Grant, P. E.
Groenewold, N. A.
Gunning, F. M.
Gur, R. E.
Gur, R. C.
Hammill, C. F.
Hansson, O.
Hedden, T.
Heinz, A.
Henson, R. N.
Heuer, K.
Hoare, J.
Holla, B.
Holmes, A. J.
Holt, R.
Huang, H.
Im, K.
Ipser, J.
Jack, C. R. Jr
Jackowski, A. P.
Jia, T.
Johnson, K. A.
Jones, P. B.
Jones, D. T.
Kahn, R. S.
Karlsson, H.
Karlsson, L.
Kawashima, R.
Kelley, E. A.
Kern, S.
Kim, K. W.
Kitzbichler, M. G.
Kremen, W. S.
Lalonde, F.
Landeau, B.
Lee, S.
Lerch, J.
Lewis, J. D.
Li, J.
Liao, W.
Liston, C.
Lombardo, M. V.
Lv, J.
Lynch, C.
Mallard, T. T.
Marcelis, M.
Markello, R. D.
Mathias, S. R.
Mazoyer, B.
McGuire, P.
Meaney, M. J.
Mechelli, A.
Medic, N.
Misic, B.
Morgan, S. E.
Mothersill, D.
Nigg, J.
Ong, M. Q. W.
Ortinau, C.
Ossenkoppele, R.
Ouyang, M.
Palaniyappan, L.
Paly, L.
Pan, P. M.
Pantelis, C.
Park, M. M.
Paus, T.
Pausova, Z.
Paz-Linares, D.
Pichet Binette, A.
Pierce, K.
Qian, X.
Qiu, J.
Qiu, A.
Raznahan, A.
Rittman, T.
Rodrigue, A.
Rollins, C. K.
Romero-Garcia, R.
Ronan, L.
Rosenberg, M. D.
Rowitch, D. H.
Salum, G. A.
Satterthwaite, T. D.
Schaare, H. L.
Schachar, R. J.
Schultz, A. P.
Schumann, G.
Schöll, M.
Sharp, D.
Shinohara, R. T.
Skoog, I.
Smyser, C. D.
Sperling, R. A.
Stein, D. J.
Stolicyn, A.
Suckling, J.
Sullivan, G.
Taki, Y.
Thyreau, B.
Toro, R.
Traut, N.
Tsvetanov, K. A.
Turk-Browne, N. B.
Tuulari, J. J.
Tzourio, C.
Vachon-Presseau, É.
Valdes-Sosa, M. J.
Valdes-Sosa, P. A.
Valk, S. L.
van Amelsvoort, T.
Vandekar, S. N.
Vasung, L.
Victoria, L. W.
Villeneuve, S.
Villringer, A.
Vértes, P. E.
Wagstyl, K.
Wang, Y. S.
Warfield, S. K.
Warrier, V.
Westman, E.
Westwater, M. L.
Whalley, H. C.
Witte, A. V.
Yang, N.
Yeo, B.
Yun, H.
Zalesky, A.
Zar, H. J.
Zettergren, A.
Zhou, J. H.
Ziauddeen, H.
Zugman, A.
Zuo, X. N.
Rowe, C.
Frisoni, G. B.
Binette, A. Pichet
Bullmore, E. T.
Alexander-Bloch, A. F.
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
,
- License Information
-
More Information
Article History
Received: 9 June 2021
Accepted: 16 February 2022
First Online: 6 April 2022
Change Date: 23 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-022-05300-0
Competing interests
: E.T.B. serves on the scientific advisory board of Sosei Heptares and as a consultant for GlaxoSmithKline, Boehringer Ingelheim and Monument Therapeutics. G.S.A. has served on advisory boards of Eisai and Janssen and in speakers bureaus of Allergan, Takeda and Lundbeck. K.M.A. is an employee of Neumora Therapeutics. P.B.J. has consulted for MSD. L. Palaniyappan reports personal fees from Janssen Canada for participating in an Advisory Board (2019) and Continuous Professional Development events (2017–2020), Otsuka Canada for Continuous Professional Development events (2017–2020), SPMM Course Limited, UK for preparing educational materials for psychiatrists and trainees (2010 onwards), Canadian Psychiatric Association for Continuous Professional Development events (2018–2019); book royalties from Oxford University Press (2009 onwards); institution-paid investigator-initiated educational grants with no personal remunerations from Janssen Canada, Sunovion and Otsuka Canada (2016–2019); travel support to attend a study investigator’s meeting organized by Boehringer-Ingelheim (2017); travel support from Magstim Limited (UK) to speak at an academic meeting (2014); none of these activities are related to this work. T.R. has received honoraria from Oxford Biomedica. A.P.S. has consulted for Janssen, Biogen, Qynapse, and NervGen. R.T.S. has received consulting income from Octave Bioscience and compensation for scientific review duties from the American Medical Association, the US Department of Defense, the Emerson Collective, and the National Institutes of Health. R.A.S. has consulted for Janssen, AC Immune, NervGen and Genentech. D.J.S. has received research grants and/or consultancy honoraria from Discovery Vitality, Johnson & Johnson, Lundbeck, Sanofi, Servier, Takeda and Vistagen. J. Suckling has consulted for GW Pharmaceuticals, Claritas HealthTech, Fundacion La Caixa and Fondazione Cariplo. All other authors declare no competing interests.
